Evaluation of 12- and 24-month survival rates after treatment with masitinib in dogs with nonresectable mast cell tumors.
Hahn K.A.
,
Legendre A.M.
,
Shaw N.G.
,
B. Phillips
,
Ogilvie G.K.
,
Prescott D.M.
,
Atwater S.W.
,
Carreras J.K.
,
Lana S.E.
,
T. Ladue
,
A. Usk
,
Kinet J.P.
,
Pascal Dubreuil
,
A. Moussy
,
O. Hermine
(1)
Hahn K.A.
- Function : Author
Legendre A.M.
- Function : Author
Shaw N.G.
- Function : Author
B. Phillips
- Function : Author
Ogilvie G.K.
- Function : Author
Prescott D.M.
- Function : Author
Atwater S.W.
- Function : Author
Carreras J.K.
- Function : Author
Lana S.E.
- Function : Author
T. Ladue
- Function : Author
A. Usk
- Function : Author
Kinet J.P.
- Function : Author
Pascal Dubreuil
- Function : Author
A. Moussy
- Function : Author
O. Hermine
- Function : Author
- PersonId : 756140
- ORCID : 0000-0003-2574-3874
- IdRef : 069884927